new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing

Merck will soon market new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing.

The new tabs come in two strengths...35 and 70 mg.

The 35 mg tab is for patients on 5 mg/d to PREVENT osteoporosis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote